30 Years of Evidence
Featured Content
pancreatic cancer awareness
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
pancreatic cancer awareness
Long-Term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-Metastatic Pancreatic Cancer
pancreatic cancer awareness
Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and TomoTherapy for advanced cervical cancer
Li D, Wang D, Feng S, Chen Q, Sheng X, Jia J, Yan X, Zhu J, and Yin Y | Oncol Lett | 2022
High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
Tomita N, Soga N, Ogura Y, Hayashi N, Kageyama T, Ito M, Koide Y, Yoshida M, Kimura K, Makita C, Tachibana H, Kodaira T | J Cancer Res Clin Oncol | 2016
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study
Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell’Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C | Clin Oncol | 2016
High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
Yamazaki H, Masui K, Suzuki G, Nakamura S, Shimizu D, Nishikawa T, Okabe H, Yoshida K, Kotsuma T, Tanaka E, Otani K, Yoshioka Y, Ogawa K | Cancers (Basel) | 2018
Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost for Clinically Node-Positive Prostate Cancer: A Single-Institutional Retrospective Study
Onishi M, Kawamura H, Murata K, Inoue T, Murata H, Takakusagi Y, Okonogi N, Ohkubo Y, Okamoto M, Kaminuma T, Sekihara T, Nakano T, Ohno T | Cancers (Basel) | 2021
Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes
Ferrera G, D’Alessandro S, Cuccia F, Serretta V, Trapani G, Savoca G, Mortellaro G, Lo Casto A | J Cancer Res Clin Oncol | 2022
Moderate Hypofractionated Helical TomoTherapy for Older Patients with Localized Prostate Cancer: Long-term Outcomes of a Phase I-II Trial
Cui D, Du L, Yu W, Cai B, Meng L, Yang J, Luo Y, Chen J, and Ma L | Radiol Oncol| 2022
Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation
Murthy V, Gupta P, Baruah K, Krishnatry R, Joshi A, Prabhash K, Noronha V, Menon S, Pal M, Prakash G, Bakshi G | Clin Oncol | 2019
Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer – PubMed (nih.gov)
Shi Z, Yang J, Kong W, Qiu X, Lu C, Liu J, Liu B, and Du J | Front Oncol | 2022
Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma
Yoon HI, Lee IJ, Han KH, Seong J | J Cancer Res Clin Oncol | 2014
Conventional fractionated helical tomotherapy for patients with small to medium hepatocellular carcinomas without portal vein tumor thrombosis
Jung J, Kong M, Hong SE | Onco Targets Ther | 2014
Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma
Chen YX, Zhuang Y, Yang P, Fan J, Zhou J, Hu Y, Zhu WC, Sun J, Zeng ZC | Technol Cancer Res Treat | 2020
A first report of tumour-tracking radiotherapy with helical tomotherapy for lung and liver tumours: A double case report
Okada W, Doi H, Tanooka M, Sano K, Nakamura K, Sakai Y, Shibata M, Tanaka M | SAGE Open Med Case Rep | 2021
Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage
Bae SH, Cho KH, Kim YS, Kim SG, Yoo JJ, Lee JM, Lee MH, Lim S, Jung JH, and Lim SH | Transl Cancer Res | 2022
Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma
Kishan AU, Cameron RB, Wang PC, Alexander S, Qi SX, Low DA, Kupelian PA, Steinberg ML, Lee JM, Selch MT, Lee P | Pract Radiat Oncol | 2015
Stereotactic Re-irradiation of Sternal Metastases Using Skin Surface Fiducial Markers and Real-Time Motion Synchronization
Bachmann N, Loebner HA, Althaus A, Hemmatazad H. | Cureus Competition | 2025
Precision Treatment of Pulmonary Sarcoma Metastasis Using Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy: A Case Report
Stergioula A, Kormas T, Kokkali S, Kyriazoglou A, Pantelis E. | Cureus Competition | 2025
CyberKnife Versus Four-Dimensional Computed Tomography-Guided Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer: A Case Report
Tang L, Yao L, Li G. | Cureus Competition | 2025
Artificial Intelligence (AI)-Driven Adaptive Motion Management in Helical and Robotic Radiotherapy: Innovations, Challenges, and Future Directions
Panda DK, Das SR, Kumar S. | Cureus Competition | 2025
A Quality Control Procedure for Single Fiducial Tracking of Lung Lesions.
Descovich M, Lau E, Hasse K, Gottschalk A. | Cureus Competition | 2025
Salvage Radiosurgery After Brachytherapy for Locally Recurrent Prostate Cancer With Real-Time Adaptive Motion Management Using Previously Implanted Brachytherapy Seeds as Fiducial Markers
Yu JB, Grew DJ, Singh C, Sculley E, Jones A, Munbodh R. | Cureus Competition | 2025
CyberKnife Staged Radiotherapy for Elderly Patients With Poorly Differentiated Lung Adenocarcinoma: A Case Report and Dosimetric Analysis
Gu S, Liu X, Du L, Ju Z, Wang H, Sun J, Dai X. | Cureus Competition | 2025
Excellent Outcomes With Stereotactic Body Radiotherapy in an Elderly Patient With Locally Progressive Immunotherapy-Resistant Renal Cell Carcinoma
Miriam Torrisi, Laura Giannini, Roberta Tummineri, Chiara Lucrezia Deantoni, Andrei Fodor | Cureus Competition | 2025
